National Immunisation Program
Exciting news, Fluger clients! As the National Immunisation Program Vaccinations in Pharmacy (NIPVIP) expands to pharmacies on 1st January 2024, you’ll be among the first to access seamless claims for the NIPVIP program through Fluger’s powerful software.
This means you can:
- Offer free NIP vaccines to eligible patients, protecting your community and expanding your service range.
- Simplify claims with Fluger’s automation – no more paperwork headaches, just focus on patient care.
- Get paid quickly and accurately – Fluger ensures you receive the full NIP reimbursement you deserve.
But that’s not all! We’re also extending this opportunity to new pharmacies looking to join the NIPVIP rollout. Partner with Fluger and you’ll be ready to:
- Hit the ground running in January with a compliant and efficient system.
- Attract new customers seeking convenient NIP vaccinations.
- Boost your revenue with a wider range of billable services.
Whether you’re an existing Fluger user or looking for a future-proof pharmacy solution, here’s why choosing Fluger for NIPVIP is a no-brainer:
- Unmatched automation: Fluger automatically captures and submits NIPVIP claims, saving you hours and eliminating errors.
- Real-time eligibility checks: Ensure you only vaccinate eligible patients, avoiding claim rejections.
- Comprehensive reporting: Track your NIPVIP performance and identify growth opportunities.
- Expert support: Our dedicated team is here to answer your questions and guide you through the process.
- Diphtheria-tetanus-pertussis vaccines
- Human papillomavirus (HPV)
- Measles-mumps-rubella vaccine (MMR)
- Meningococcal ACWY
- Pneumococcal
- Herpes zoster (Shingles)
- Japanese encephalitis (JE)
- Mpox/ smallpox/ vaccinia virus (mpox)
- Diphtheria toxoidPertussis antigenTetanus toxoid
- Hepatitis B vaccine
- Human Papillomavirus vaccine
- Haemophilus influenzae type b vaccine
- Influenza and coryza vaccine ‘Influenza vaccine’ (with conditions)
- Measles vaccine
- Mumps vaccine
- Rubella vaccine
- Meningococcal vaccine (ACWY) (quadrivalent) conjugate vaccine
- Meningococcal B
- Meningococcal C
- Poliomyelitis vaccine
- Varicella vaccine
- Zoster vaccine (Recombinant varicella zoster virus glycoprotein e antigen vaccine)
Don’t miss out on this game-changing opportunity! Contact Fluger today to:
- Secure your spot for January’s NIPVIP rollout.
- Learn more about Fluger’s NIPVIP solution.
- Discuss how Fluger can help you grow your pharmacy in 2024 and beyond.
Remember, Fluger clients are always first in line for the latest advancements. Join us and be at the forefront of the NIPVIP revolution!
P.S. Share this post with your pharmacy network! Let’s help everyone benefit from the NIPVIP program.
